Lets get straight to the heart of the matter
In the multicenter, randomized, placebo-controlled Q-SYMBIO trial, a daily CoQ10 intake of 300mg was found to significantly reduce the incidence of a major adverse cardiovascular event in 15% of subjects (63 out of 420 participants),57 and a 2025 meta-analysis determined that long-term supplementation with doses as low as 100mg significantly reduced users systolic blood pressure.58 IM8 has perhaps too little CoQ10 to make a noticeable difference in, say, heart attack risk, but it seems well-dosed for people looking to alleviate hypertension
Bacteriostatic water 0.9% continues to be studied in research settings focused on sterile solution preparation, laboratory handling procedures, and multi-use antimicrobial preservation systems under controlled conditions
doi: 10.1161/01.STR.0000157663.43209.a2
A realistic timeline: 48 weeks: early subjective changes may appear 812 weeks: body-composition changes may become more noticeable 36 months: better window to evaluate progress Ipamorelin should not be marketed as a substitute for semaglutide, tirzepatide, or clinically indicated obesity treatment
